Biotech events - Theoria Creative

Bio International Convention
2024-06-03 - 2024-06-06
BUILDING CONNECTIONS,
BREAKING BARRIERS
When the stakes are this high, we can’t go it alone. BIO unites a global network of business leaders, policymakers, investors and scientists for a common purpose: curing patients, protecting the planet, and nourishing humanity.

Annual Oncology Innovation Summit: Insights for ASCO & EHA
2024-05-31 - 2024-06-04
Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.
The 2024 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Lynn Schuchter’s Presidential theme: The Art and Science of Cancer Care: From Comfort to Cure.

Annual Meeting of the International Society for Cell & Gene Therapy (ISCT)
2024-05-29 - 2024-06-01
CUTTING EDGE TRANSLATIONAL CONTENT
Connect with global experts from across academic, regulatory, and industry. Participate in robust debates, collaborate on developing solutions to sector challenges, and secure a front-row seat to presentations and conversations advancing the field of cell and gene therapy.
50+ Roundtable Sessions: Developed by harnessing the expertise of key opinion leaders from ISCT expert committees, ISCT 2024 roundtable sessions provide an interactive platform for in-depth discussions and debates on pivotal subjects including iPSCs, exosomes, CAR-Ts, artificial intelligence, bio-manufacturing and regulatory harmonization.
Join our roundtable sessions to remain well-informed on solutions to the sector’s most pressing challenges, engage in conversations propelling the industry forward, and forge connections with potential future collaborators.
Translational Pathway Program: Immerse yourself in the future of cell and gene therapy with thought-provoking talks and presentations from the most esteemed cell and gene therapy leaders from across the globe. Our Translational Pathway Program provides key education and data on the most novel research spanning the spectrum of translation including science and innovation, translation to the clinic, first in human to clinical acceleration, launch and patient access.
Attend our plenary and concurrent sessions to discover the latest breakthroughs in gene-edited EVs, autologous and allogeneic iPSC clinical trials, CAR-Ts, NK cells, Tregs, point-of-care manufacturing, clinical site qualification standardization, investment and partnering.
Global Showcases & Corporate Sessions: Hear directly from industry leaders representing prominent international organizations to discover the current status of commercialization efforts in the cell and gene sector. Gain firsthand knowledge and education about the revolutionary technologies on the horizon that are poised to define the future of cell and gene therapy.

Pharma Partnering Summit
2024-05-14 - 2024-05-15
The Pharma Partnering US Summit 2024 is an exclusive and one of the most prestigious life sciences deal-making international conferences coming to San Diego, CA, on the 14th & 15th of May 2024.
This platform brings together senior executives and professionals from different parts of the world, focusing on business development and licensing, R&D collaborations, commercialization and distribution deals, fundraising, investments, alliances, M&A, Going Public, and partnering opportunities in the broader aspects.
Finally, San Diego has a supportive regulatory environment that encourages innovation and growth in the biotech industry. The state of California has implemented several initiatives to promote the life sciences sector, including tax incentives, grants, and loans for biotech companies.

2024 AAPS National Biotechnology Conference
2024-05-13 - 2024-05-16
Track 1: Advances in Discovery, Formulation, and Delivery of New Modalities
A tremendous rise in the biologics market has driven significant interest in their discovery and in using novel drug delivery systems to enable drug delivery via different routes. This track focuses on aspects of the discovery and development of biologics and new modalities. Submissions are invited on topics related to multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, cells, and allogenic and synthetic cells. Discussions are encouraged on diverse strategies for the discovery, formulation, and delivery of these modalities to address unmet medical needs.
Track 2: Novel Strategies to Advance Biotherapeutic Development
Advances in therapeutic development for targeted delivery, platform technology, high-content bioanalysis, and data science.

ASGCT 27th Annual Meeting
2024-05-07 - 2024-05-11
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. ASGCT’s annual meeting brings together more than 3,400 professionals including scientists, physicians, and patient advocates.

APA 2024 Annual Meeting
2024-05-04 - 2024-05-08
Join APA for five days of sessions, courses, and more in the vibrant New York City to leave you feeling inspired, energized, and better prepared. Connect with colleagues and industry experts from around the globe. Choose from 500+ educational sessions led by psychiatry and mental health expert educators. Engage with an array of exhibitors featuring the latest therapeutics and technologies in psychiatry.
Can’t make it to NYC? We’ve got you covered. The Virtual Annual Meeting will feature live-streams of a limited selection of sessions from New York, all accessible from the comfort of your home or office, or anywhere with a secure internet connection.
Register before February 6 for our best Early Registration rates for the in-person-only experience. Registration for the virtual-only experience opens in February 2024.

Immunology 2024
2024-05-03 - 2024-05-07
Join us Friday, May 3, to Tuesday, May 7, in Chicago for the leading annual all-immunology event worldwide!
Explore the latest developments in your field.
Attend lectures by the world’s most prominent scientists.
Speak with poster authors presenting their cutting-edge data.
Network with colleagues from around the world.
There has never been a more important time for the immunology community to gather and share the latest cutting-edge science!

ASMB - Pathobiology 2024: Mechanisms of Disease
2024-04-20 - 2024-04-23
Tissue, Matrix, and Pathobiology is an exciting new multidisciplinary and collaborative joint meeting of the American Society for Matrix Biology (ASMB), The Histochemical Society (HCS), and the American Society for Investigative Pathology (ASIP). The Program Committee has put together a fantastic four-day lineup of speakers, career sessions, workshops, and events—and can’t wait to welcome you in Salt Lake City!
The annual meeting includes symposia and workshops communicating cutting edge scientific sessions, commingled with educational and professional development sessions appealing to trainees and junior faculty. Reflecting the ASIP membership, there will be a strong emphasis on:
Liver Pathobiology
Neuropathology
Gene Expression
Inflammation
Immunopathology
Vascular Biology
Neoplasia
Endothelial and Epithelial Cell Biology
Cancer Pathobiology
Fundamental Cell Biology

Bio-IT World - AI for Drug Discovery and Development
2024-04-16 - 2024-04-17
Leverage Artificial Intelligence and Machine Learning for Optimal Speed and Efficiency in Advancing Drug Discovery and Development Pipelines
The AI for Drug Discovery and Development track delves into the opportunities and obstacles faced by biopharma entities as they leverage the capabilities of artificial intelligence and machine learning technologies to optimize and expedite the entire drug discovery and development process, spanning from the initial stages to practical implementation. Speakers will examine AI’s role in reshaping our comprehension of diseases and target identification, approaches that blend AI with human expertise to identify and validate targets, and how it can elevate the field of chemical drug design and precision medicine. Additionally, we’ll explore how AI and machine learning initiatives measure up against the established and proven methods of drug discovery leading to successful market launches.

S2S - Science 2 Startup
2024-04-10
S2S is a forum for top scientists from around the world to present their ideas and interact with leading investors and executives in the Boston biotechnology hub.
Over 8 years, investigators from institutions including Brown, Carnegie Mellon, Columbia, Harvard, Johns Hopkins, MIT, Northwestern, NYU, Purdue, Scripps, UCLA, University of Iceland, University of Ottawa, University of Pennsylvania, University of Pittsburgh, Yale, and many more have presented their startup ideas at S2S and its precursor, the University Research and Entrepreneurship Symposium (URES).

AACR Annual Meeting
2024-04-05 - 2024-04-10
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

World Vaccine Conference
2024-04-02 - 2024-04-04
The Start-to-Finish of Vaccines
From research, immune profiling & clinical trials to manufacture and access.
Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more

Gene Therapy for Rare Disorders Summit
2024-03-26 - 2024-03-29
This past year has seen more gene therapies approved by the FDA than the previous five years combined, and almost triple the number of clinical trials in gene therapy have been initiated in H1 of 2023 compared to the same time frame in the previous year.
To maximize the value of your late-stage gene therapy assets, the 7th Gene Therapy for Rare Disorders Summit is returning to tackle head-on the significant clinical, manufacturing, regulatory, and commercial challenges facing gene therapy programs today.
Bringing together key figures from industry, regulatory bodies, patient non-profits, payers, and key service providers, this is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic.
Join us to leverage essential insights from over 300 peers from leading biopharma companies with direct experience in driving gene therapies through the clinic and into the market. Keep your finger on the pulse, form connections with top decision-makers, and address your specific clinical, manufacturing, regulatory, and commercial bottlenecks to safeguard against costly delays and progress your gene therapies through the pipeline quickly and safely.

Cell & Gene Therapy at Pharma USA 2024
2024-03-26 - 2024-03-27
Accelerate innovation commercialization. Expand market footprint with proven potential.
With so many scientific breakthroughs in regenerative medicine, commercial challenges have never been so urgent. Consequences have been suffered by both pharma and patients when we fail to overcome the barriers from lab to sites of care.
To continuedly create impact from trial to post-launch, we must proactively work with patients, HCPs, regulators, payors and partners to amplify the values of innovation for all stakeholders, and eventually will be able to expand our footprint and pave the road to the next generation medicine.
Rome wasn’t built in a day, but at Pharma USA 2024 (March 26-27, Philadelphia) we’re laying the foundations for your frontline therapy by gathering the industry’s best minds and generating solutions to the space’s biggest commercial challenges.

Pharma USA - Reuters Events
2024-03-26 - 2024-03-27
North America’s largest cross-functional pharma gathering
Rapid healthcare reforms are finally paving the way for affordable access to medicines, but your commercial model is now outdated. The future of life-saving treatments reaching patients is under threat.
The race is on to adapt. How quickly you can create and scale patient value to competing stakeholders will determine whether future scientific innovation will succeed. Those afraid to accelerate will be left behind.
We must empower HCPs with crucial insights, adapt to evolving payer needs, scale with digital & tech and co-create with patients. Only then will we achieve exceptional outcomes and prove to be a trusted ally.
Reuters Events: Pharma USA 2024 is where pioneers from Commercial, Marketing, Medical Affairs, RWE, Market Access, Patient Engagement, and key stakeholders, will come together to deliver value to overcome the challenges that threaten the future viability of innovation.
Join over 1,200 of North America’s pharma pioneers, leading solutions providers, and patient advocates to sharpen short-term strategy and unite for a long-term future to exceed all stakeholder desires and cement pharma’s role as an integral pillar of the healthcare system.

Fierce Business Development and Licensing (BD&L) Summit for Life Sciences
2024-03-11 - 2024-03-12
Successfully identify and execute strategic partnerships, licensing, and M&A Deals
The Fierce Business Development and Licensing (BD&L) Summit for Life Sciences brings together key deal-makers and serves as an open forum for cross-functional business development, due diligence, finance, and legal teams to share valuable insights and actionable strategies on successfully sourcing and evaluating new opportunities, conducting due diligence, and structuring licensing agreements and M&A deals.

Cowen's 44th Annual Health Care Conference
2024-03-04 - 2024-03-06
This is an ideal forum for objective first-hand updates on both marketed and emerging products across the sector with more than 375 public and private companies across the entire health care spectrum. Cowen research analysts will host public companies in fireside chat sessions and corporate panel discussions to engage in enlightening discussion with management teams. Public and private companies will also host investor one-on-one meetings throughout the three days of the conference to facilitate interactive participation with event attendees.
As always, the conference will include a wide array of high-interest topical panels, including discussion of key medical devices, life science and diagnostic tools, therapeutics, health care delivery, COVID-19 and the evolving political and regulatory landscape, all featuring our renowned medical, scientific, industry, legal and political consultants. Cowen analysts will provide data-rich content slides to drive deeper discussion and therefore insight, including comparison of clinical expert and payor views, while also posing investor questions submitted to the panel for discussion.

Global Life Science Partnering & Investor Conference
2024-02-27 - 2024-02-29
The Premier Partnering & Investor Event of the Year
This conference is an exclusive global partnering and investor forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us next year, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.

Bio CEO & Investor Conference
2024-02-26 - 2024-02-27
For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

6th International Conference on PharmScience Research & Development
2024-02-21 - 2024-02-24
Pharma R&D continues the successful series of meetings over the past four years. Over the last year, we have seen pharma innovation advance at an incredible pace to tackle the COVID-19 pandemic. As the need for improved productivity and efficiency in drug and biomedical R&D intensifies, pharmaceutical companies carefully choose their investment in technology innovation. Pharma R&D Conferences are the most important conferences taking place annually with its participants from over 35 countries in the region and beyond. The Conference is a great platform to benchmark and network with an exclusive group of senior peers. We are here to help and accelerate the effectiveness of your marketing strategies and stay ahead of the competition. The comprehensive 3-day program—packs with pharma and technology presentations, interactive panel discussions, and visionary keynotes—is designed to maximize collaboration and innovation. Get ready for more interaction and networking at 5th International Conference on PharmScience Research & Development at Las Vegas, NV, USA during February 21-23, 2023.

Reproductive Health Innovation Summit
2024-02-13 - 2024-02-14
RHIS provides a platform that enables the industry to collectively improve reproductive health outcomes across both male and female sectors. Through uplifting partners, facilitating connections, and providing access to senior leaders, RHIS enables businesses to thrive. As we look forward to the 4th RHIS, we continue to uphold its commitment to meeting the essential demands of the reproductive health landscape. Connecting industry c-suite to showcase disruptive innovations, forge critical partnerships and drive sector growth across reproductive health. “If you want to be part of this ecosystem and if you are truly into driving advances in women’s health but specifically in reproductive medicine, then this is the place for you”

AHA International Stroke Conference 2024
2024-02-07 - 2024-02-09
The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease and brain health. Network with thousands from endless combinations of expertise, experience and background. Form life-long collaborations and engage in exceptional education and science through presentations on the latest research from global thought leaders.
Join the conversation across numerous topics that emphasize basic, clinical and translational science. Discover a vast network of professionals collaborating towards understanding stroke pathophysiology, developing effective therapies and exploring brain health and stroke recovery. Experience an array of specialized topics where your expertise is essential. Take part in this unique and career-essential gathering of compelling science and professional connections.

The SIO 2024 Annual Scientific Meeting
2024-01-25 - 2024-01-27

Precision Medicine World Conference (PMWC) 2024
2024-01-24 - 2024-01-26
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.
Since 2009, recognized as a vital cornerstone for all constituents of the health care and biotechnology community, PMWC provides an exceptional forum for the exchange of information about the latest advances in technology (e.g. DNA sequencing technology), in clinical implementation (e.g. cancer and beyond), research, and in all aspects related to the regulatory and reimbursement sectors.

ASCO Gastrointestinal Cancers Symposium
2024-01-18 - 2024-01-20
The 2024 ASCO GI Cancers Symposium offers the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care.
Collaboration across specialties and disciplines is vital in the treatment of patients with GI cancers—this is the only global GI oncology meeting with dedicated multidisciplinary committees and faculty. Make connections with colleagues, presenters, and GI specialists from around the world to advance your own knowledge and contribute to the progress of personalized GI cancer care.

RESI JPM 2024(Redefining Early-stage Investments)
2024-01-09 - 2024-01-10
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Fierce JPM Week 2024
2024-01-09 - 2024-01-10
Connecting Minds, Igniting Change, Navigating the Future of Biopharma and Healthcare
A pivotal election, new regulations, and an array of technological advancements are poised to usher in a year marked by innovation and change for biopharma and healthcare.
From thought-provoking discussions on the ever-evolving deal dynamics within the industry to unique insights on the regulatory landscape, treatment breakthroughs, and the strategic deployment of AI, some of the greatest minds in pharma and healthcare will convene to explore the most pressing issues and exciting opportunities on the horizon.

BIO Partnering at JPM Week
2024-01-08 - 2024-01-12
BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.

The CSSi LifeSciences Partnering Forum during the Annual J.P. Morgan Healthcare Conference
2024-01-08 - 2024-01-11
The event provides a unique opportunity for participating sponsors to meet emerging and established life science companies that require a broad range of professional services to advance their products to commercial success. In 2023, we had 1000+ in-person participants from 600+ companies. The Forum drew companies and organizations from 23 countries including Australia, Canada, Hong Kong, Ireland, Israel, France, Germany, Italy, Japan, Korea, Singapore, Switzerland and the United Kingdom.
